Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:06 PM
Ignite Modification Date:
2025-12-24 @ 9:06 PM
NCT ID:
NCT02260804
Eligibility Criteria:
Inclusion Criteria:
* Confirmed diagnosis of low tumour burden, CD20+ follicular lymphoma
* Ann Arbor Stage II, III or IV
Exclusion Criteria:
* Has receive rituximab
* Allergies or hypersensitivity to murine, chimeric, human or humanised proteins
* Previous treatment for NHL
* Any malignancy
* Current or recent treatment with any other investigational medicinal product or device
* pregnant or lactating
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02260804
Study Brief:
Protocol Section:
NCT02260804